ट्रेड Novavax NVAX

बेचें
 खरीदें

Novavax लाइव चार्ट

5m 15m 30m 1h 4h 1d 1w

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

Novavax news

2021 मई 11, 13:20

US pre-market: selling unabated

2021 मई 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 मई 26, 08:04

Leg up: stocks make new ground, travel stocks soar

नवीनतम समाचार

और दिखाएं
Liam James 2025 Aug 22, 15:20

Market Review & Investment Insights: August 2025

Noah Lee 2025 Aug 22, 15:20

Trump Threatens to Fire Fed Governor Lisa Cook Amid Mortgage Fraud Allegations

Liam James 2025 Aug 22, 15:20

Wall Street Reacts: Powell Hints at September Rate Cut, But Cautiously

Liam James 2025 Aug 22, 14:20

Dollar Bullish Sentiment Rises Ahead of Powell Speech, Forex Options Show

Ava Grace 2025 Aug 22, 12:20

Syria to Revalue Currency: Removing Zeros in Bid to Restore Confidence

Noah Lee 2025 Aug 22, 10:20

India, Russia Expand Trade Amid US Tariff Pressure

Ava Grace 2025 Aug 22, 08:20

Trump Administration Eyes Repurposing Chip Act Funds for Critical Minerals

Emma Rose 2025 Aug 22, 08:20

Powell's Jackson Hole Speech: Shaping the Fed's Future Amidst Economic Uncertainty

जानकारी

स्प्रेड

0.05

स्प्रेड (%)

0.6394 %

लीवरेज

1:10

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

सोमवार

13:31 - 19:59

मंगवार

13:31-19:59

बुधवार

13:31-19:59

गुरुवार

13:31-19:59

शुक्रवार

13:31-19:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

1239279872

बकाया शेयर

162422000

प्राप्ति की तिथि (आगे)

2019-05-10

लाभांश आय 

2019-05-10

पूर्व-लाभांश तिथि

अग्रिम वार्षिक लाभांश दर 

0

अग्रिम वार्षिक लाभांश आय

0

EPS

2.22

इस उपकरण के बारे में अधिक जानें

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें
view_all_instruments

latest_education_articles

और दिखाएं
Trustpilot